Oragenics
OGEN
10 hedge funds and large institutions have $18.5M invested in Oragenics in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
36% less capital invested
Capital invested by funds: $28.8M → $18.5M (-$10.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$59.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$29.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$29.8K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$5K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1K |
OGEN Hedge Fund Activity: Q3 2014 in Review
10 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2014, worth a combined $18.5M — down 36% from $28.8M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new OGEN positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $59.7K. The largest seller was Janney Montgomery Scott, cutting an estimated $29.8K.
- 10 institutional investors held Oragenics (OGEN) as of Q3 2014, up from 8 in Q2 2014.
- Funds reported $18.5M of Oragenics stock for Q3 2014, down 36% quarter-over-quarter.
- 2 funds opened new Oragenics positions in Q3 2014 and 0 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q3 2014 was Jacobs Levy Equity Management, an estimated $59.7K added.
- The largest Oragenics seller in Q3 2014 was Janney Montgomery Scott, an estimated $29.8K sold.
Based on aggregated 13F filings for Q3 2014.